HLN vs. RDY

Last updated Apr 2, 2026

Compare and contrast key facts about Haleon plc (HLN) and Dr. Reddy's Laboratories Limited (RDY).

Performance

HLN vs. RDY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Haleon plc (HLN) and Dr. Reddy's Laboratories Limited (RDY). The values are adjusted to include any dividend payments, if applicable.

HLN vs. RDY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
HLN Haleon plc	-1.38%	7.84%	17.99%	4.21%	7.96%
RDY Dr. Reddy's Laboratories Limited	-4.06%	-10.53%	14.13%	36.47%	-5.69%

Fundamentals

Market Cap HLN : $44.68B RDY : $11.22B
EPS HLN : $0.62 RDY : $67.92
PE Ratio HLN : 16.16 RDY : 0.20
PEG Ratio HLN : 2.50 RDY : 0.01
PS Ratio HLN : 2.33 RDY : 0.03
PB Ratio HLN : 2.72 RDY : 0.03
Total Revenue (TTM) HLN : $19.27B RDY : $345.83B
Gross Profit (TTM) HLN : $12.29B RDY : $188.26B
EBITDA (TTM) HLN : $4.76B RDY : $93.77B

Returns By Period

In the year-to-date period, HLN achieves a -1.38% return, which is significantly higher than RDY's -4.06% return.

HLN

• 1D: -0.40%
• 1M: -8.28%
• YTD: -1.38%
• 6M: 10.65%
• 1Y: -0.34%
• 3Y*: 8.45%
• 5Y*: —
• 10Y*: —

RDY

• 1D: -2.74%
• 1M: -6.33%
• YTD: -4.06%
• 6M: -5.14%
• 1Y: 3.00%
• 3Y*: 6.72%
• 5Y*: 2.48%
• 10Y*: 4.79%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

HLN vs. RDY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HLN

HLN Risk / Return Rank: 36
HLN Sharpe Ratio Rank: 39
HLN Sortino Ratio Rank: 32
HLN Omega Ratio Rank: 32
HLN Calmar Ratio Rank: 39
HLN Martin Ratio Rank: 39

RDY

RDY Risk / Return Rank: 41
RDY Sharpe Ratio Rank: 44
RDY Sortino Ratio Rank: 36
RDY Omega Ratio Rank: 37
RDY Calmar Ratio Rank: 44
RDY Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HLN vs. RDY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Haleon plc (HLN) and Dr. Reddy's Laboratories Limited (RDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HLN	RDY	Difference
Sharpe ratio Return per unit of total volatility	-0.01	0.13	-0.14
Sortino ratio Return per unit of downside risk	0.14	0.33	-0.19
Omega ratio Gain probability vs. loss probability	1.02	1.04	-0.03
Calmar ratio Return relative to maximum drawdown	-0.06	0.14	-0.20
Martin ratio Return relative to average drawdown	-0.11	0.25	-0.36
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HLN vs. RDY - Sharpe Ratio Comparison

The current HLN Sharpe Ratio is -0.01, which is lower than the RDY Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of HLN and RDY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	HLN	RDY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.01	0.13	-0.14
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.11	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.18	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.41	0.36	+0.05

Correlation

The correlation between HLN and RDY is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

HLN vs. RDY - Dividend Comparison

HLN's dividend yield for the trailing twelve months is around 1.76%, more than RDY's 0.68% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HLN Haleon plc	1.76%	1.73%	1.65%	1.26%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
RDY Dr. Reddy's Laboratories Limited	0.68%	0.65%	0.60%	1.39%	1.48%	1.04%	0.46%	0.71%	0.00%	0.78%	0.62%	0.63%

Drawdowns

HLN vs. RDY - Drawdown Comparison

The maximum HLN drawdown since its inception was -24.83%, smaller than the maximum RDY drawdown of -60.62%. Use the drawdown chart below to compare losses from any high point for HLN and RDY.

Drawdown Indicators

	HLN	RDY	Difference
Max Drawdown Largest peak-to-trough decline	-24.83%	-60.62%	+35.79%
Max Drawdown (1Y) Largest decline over 1 year	-23.11%	-19.60%	-3.51%
Max Drawdown (5Y) Largest decline over 5 years	—	-35.25%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-47.13%	—
Current Drawdown Current decline from peak	-12.09%	-19.52%	+7.43%
Average Drawdown Average peak-to-trough decline	-7.99%	-21.94%	+13.95%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.54%	10.96%	+1.58%

Volatility

HLN vs. RDY - Volatility Comparison

The current volatility for Haleon plc (HLN) is 7.14%, while Dr. Reddy's Laboratories Limited (RDY) has a volatility of 7.69%. This indicates that HLN experiences smaller price fluctuations and is considered to be less risky than RDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HLN	RDY	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.14%	7.69%	-0.55%
Volatility (6M) Calculated over the trailing 6-month period	16.43%	16.19%	+0.24%
Volatility (1Y) Calculated over the trailing 1-year period	23.67%	23.81%	-0.14%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.04%	22.93%	+1.11%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.04%	26.44%	-2.40%

Financials

HLN vs. RDY - Profitability Comparison

The chart below illustrates the profitability comparison between Haleon plc and Dr. Reddy's Laboratories Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

HLN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Haleon plc reported a gross profit of 3.59B and revenue of 5.52B. Therefore, the gross margin over that period was 65.0%.

RDY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Dr. Reddy's Laboratories Limited reported a gross profit of 44.23B and revenue of 87.27B. Therefore, the gross margin over that period was 50.7%.

HLN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Haleon plc reported an operating income of 1.25B and revenue of 5.52B, resulting in an operating margin of 22.7%.

RDY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Dr. Reddy's Laboratories Limited reported an operating income of 14.24B and revenue of 87.27B, resulting in an operating margin of 16.3%.

HLN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Haleon plc reported a net income of 855.69M and revenue of 5.52B, resulting in a net margin of 15.5%.

RDY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Dr. Reddy's Laboratories Limited reported a net income of 12.10B and revenue of 87.27B, resulting in a net margin of 13.9%.